Abstract
The pharmacological treatment of COVID-19 has evolved in the months since the description of the disease. Published observational studies and, above all, clinical trials have highlighted drugs that are useful as well as ruled out any benefit from other drugs used at the beginning of the pandemic. The pathogenesis of the disease has suggested that patients may benefit from the administration of both antivirals, mainly in the earliest stages, and anti-inflammatory/immunomodulatory medications in more advanced stages. We present a short review of the drugs used and under investigation for the treatment of COVID-19.
All Keywords
【초록키워드】 COVID-19, Treatment, clinical trial, pandemic, Pathogenesis, antivirals, clinical trials, drug, observational study, Patient, medication, administration, pharmacological treatment, treatment of COVID-19, stages, description, benefit, the disease, suggested, 【제목키워드】 COVID-19, therapy, Immunotherapy,
【초록키워드】 COVID-19, Treatment, clinical trial, pandemic, Pathogenesis, antivirals, clinical trials, drug, observational study, Patient, medication, administration, pharmacological treatment, treatment of COVID-19, stages, description, benefit, the disease, suggested, 【제목키워드】 COVID-19, therapy, Immunotherapy,
{{{ 추상적인 }}}
COVID-19의 약리학적 치료는 질병에 대한 설명 이후 몇 달 동안 발전했습니다. 발표된 관찰 연구와 무엇보다도 임상 시험은 유용한 약물을 강조했을 뿐만 아니라 전염병 초기에 사용된 다른 약물의 이점을 배제했습니다. 질병의 발병기전은 환자가 항바이러스제(주로 초기 단계)와 항염증/면역조절 약물(더 진행된 단계)의 투여로부터 혜택을 받을 수 있음을 시사했습니다. COVID-19 치료를 위해 사용 및 조사 중인 약물에 대한 간략한 검토를 제공합니다.